Minerva Neurosciences Inc (4MN)

0.3684
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    0.3684 - 0.3684
  • Type:Equity
  • Market:Germany
  • ISIN:US6033801068
  • WKN:A1171S

4MN Overview

Prev. Close
0.3673
Day's Range
0.3684-0.3684
Revenue
-
Open
0.3684
52 wk Range
0.3217-2.15
EPS
-
Volume
0
Market Cap
17.49M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
800
P/E Ratio
-
Beta
-
1-Year Change
-81.42%
Shares Outstanding
5,340,195
Next Earnings Date
-
What is your sentiment on Minerva Neurosciences?
or
Vote to see community's results!

Minerva Neurosciences Inc News

Minerva Neurosciences Inc Analysis

Minerva Neurosciences Inc Company Profile

Minerva Neurosciences Inc Company Profile

Employees
9

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company's lead product candidates are roluperidone (MIN-101), seltorexant and MIN-301. Roluperidone (MIN-101) is a compound that blocks serotonin, sigma, and α adrenergic receptors that are involved in the regulation of mood, cognition, sleep, and anxiety. The Company is developing roluperidone to treat patients with schizophrenia. Roluperidone is designed to block a specific subtype of serotonin receptor called 5-HT2A. The Company is developing seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD). MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, for the treatment of Parkinson’s disease and for other neurodegenerative disorders.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Cash+equite above 90 million. This must be at least 2$
    0
    • What is happening?? Why is it falling????
      0
      • lets go back to 4
        0
        • Will hit 4.40 with vaccine FDA approval
          0
          • based on?
            0
        • I have been following this stock since it crashed, and today I have confirmed that it rise up again in no distance time.so buy now and make a lot of money. NERV is a high volatile stock and it is for the high dreamers.Now it is down just whatch out how it will sky rocket very soon.
          4
          • Do you have shares from this company Nne?
            0
        • No comments on this stock for the past one week... Any hope for uptrend and target 4 at least?
          0
          • wait for a couple of weeks it will come back up
            0
        • Hearing JMP Securities is Reinstating its Market Outperform Rating on Minerva Neurosciences with a $9 Price Target
          0
          • in the next our it going to ******up
            0
            • What could be the status tomorrow? Bfre and after CC? Good to sell out?
              2
              • Do you thinkg it this will go up?
                2
                • 6-6.5
                  0
                • Rashad AhmadovI think this down was for this time but in future could be going up, there is to much people who have there miney on this stock for this price is not good for them a tehy will try to UP
                  0
                • 0